XML 54 R44.htm IDEA: XBRL DOCUMENT v3.3.1.900
Share-based Compensation (Tables)
6 Months Ended
Dec. 31, 2015
Share-based Compensation  
Schedule of weighted average assumptions used to estimate fair values of the stock options granted and the estimated annual forfeiture rates used to recognize the associated compensation expense and the weighted average fair value of the options granted

 

 

Six Months Ended

 

 

 

December 31, 2015

 

December 31, 2014

 

Risk-free interest rate

 

1.7 

%

1.7 

%

Expected volatility

 

48.3 

%

52.1 

%

Expected dividend yield

 

0.0 

%

0.0 

%

Forfeiture rate

 

6.5 

%

6.5 

%

Expected term (in years)

 

5.2 years

 

5.5 years

 

Weighted average fair value

 

$

26.24 

 

$

17.67 

 

 

Summary of stock option award activity

(In thousands, except for weighted average price and life data)

 

Awards

 

Weighted-
Average
Exercise
Price

 

Aggregate
Intrinsic
Value

 

Weighted
Average
Remaining
Contractual
Life (yrs.)

 

Outstanding at July 1, 2015

 

1,975

 

$

15.39

 

 

 

 

 

Granted

 

58

 

$

59.20

 

 

 

 

 

Exercised

 

(141

)

$

16.34

 

$

4,078

 

 

 

Forfeited, expired or repurchased

 

(37

)

$

31.93

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2015

 

1,855

 

$

16.36

 

$

45,523

 

6.7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Vested and expected to vest at December 31, 2015

 

1,817

 

$

16.00

 

$

45,143

 

6.7

 

Exercisable at December 31, 2015

 

1,291

 

$

10.37

 

$

38,566

 

6.0

 

 

Summary of nonvested restricted stock awards

(In thousands)

 

Awards

 

Weighted
Average Grant -
date Fair Value

 

Aggregate
Intrinsic Value

 

Non-vested at July 1, 2015

 

98

 

$

37.83

 

 

 

Granted

 

131

 

$

58.06

 

 

 

Vested

 

(57

)

$

46.87

 

$

3,302

 

Forfeited

 

(2

)

$

46.22

 

 

 

 

 

 

 

 

 

 

 

 

Non-vested at December 31, 2015

 

170

 

$

50.31

 

 

 

 

 

 

 

 

 

 

 

 

 

Schedule of allocation of share-based compensation costs recognized in the Consolidated Statements of Operations by financial statement line item

 

 

Three Months Ended

December 31,

 

Six Months Ended

December 31,

 

(In thousands)

 

2015

 

2014

 

2015

 

2014

 

Selling, general and administrative expenses

 

$

1,494 

 

$

1,251 

 

$

5,380 

 

$

2,610 

 

Research and development expenses

 

201 

 

137 

 

389 

 

257 

 

Cost of sales

 

329 

 

184 

 

629 

 

352 

 

 

 

 

 

 

 

 

 

 

 

Total

 

$

2,024 

 

$

1,572 

 

$

6,398 

 

$

3,219 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Tax benefit at statutory rate

 

$

729 

 

$

536 

 

$

2,303 

 

$

1,075